14 Nov 2025 | 5 Mins Read
Beryl Drugs' net sales drop 8.8% to Rs 5.12 crore in September 2025
Flipitmoney
Reported Standalone quarterly numbers for Beryl Drugs are: Net Sales at Rs 5.12 crore in September 2025 down 8.8% from Rs. 5.61 crore in September 2024. Quarterly Net Profit at Rs. 0.01 crore in September 2025 up 28.99% from Rs. 0.01 crore in September 2024. EBITDA stands at Rs. 0.73 crore in September 2025 up 30.36% from Rs. 0.56 crore in September 2024.